• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Deep Brain Stimulation Devices Market for Parkinson's Disease - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • Published: March 2014
  • Region: Global
  • 91 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • MEDTRONIC, Inc.
  • Sapiens Neuro
  • St Jude Medical, Inc.
  • MORE

'Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019'

A rise in the world’s aging population, increase in the number of patients living with Parkinson’s disease and growing awareness about neurological movement disorders among patients have triggered the growth of deep brain stimulation devices market.

Globally, neurological disorders are the main causes of mortality; these account for approximately 12% of total number of deaths. Of these, cerebrovascular diseases are responsible for 85% of deaths. Parkinson’s disease is the most common neurodegenerative movement disorder after Alzheimer’s. Symptoms associated with this disease include tremors, slowness of movement, muscle stiffness and trouble with balance.

Drug therapy is the most effective treatment option available to control Parkinson’s disease in the initial stages; however, a large number of medicines are required to control the disease during the advanced stages. In late stage of the disease, deep brain stimulation (DBS) surgical READ MORE >

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease (2012 & 2019)

Chapter 3 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Dynamics
3.1 Introduction
3.1.1 Drivers
3.1.1.1 Aging population inducing chronic neurological disorders such as Parkinson’s and Alzheimer’s
3.1.1.2 Technological advancements driving the growth of DBS
3.1.1.3 Favorable reimbursement policies
3.1.1.4 Increasing demand for minimally invasive surgeries
3.1.2 Restraints
3.1.2.1 Implementation of Affordable Care Act in the U.S.
3.1.2.2 Risks Involved in DBS Procedures
3.1.3 Opportunities
3.2 Porter’s Five Force Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry
3.3 Market Attractiveness Analysis of the Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography

Chapter 4 Deep Brain Stimulation Devices Market for Parkinson’s Disease, By Geography
4.1 Overview
4.1.1 Comparative Analysis: Global Deep Brain Stimulation Devices Market, By Geography, 2012 & 2019 (Value %)
4.2 North America
4.2.1 U.S.
4.2.1.1 U.S. Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.2.2 Canada
4.2.2.1 Canada Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3 Europe
4.3.1 Germany
4.3.1.1 Germany Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.2 U.K.
4.3.2.1 U.K. Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.3 France
4.3.3.1 France Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.4 Italy
4.3.4.1 Italy Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.5 Spain
4.3.5.1 Spain Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.6 Poland
4.3.6.1 Poland Deep brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.7 Netherlands
4.3.7.1 Netherlands Deep brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.8 Greece
4.3.8.1 Greece Deep brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.9 Belgium
4.3.9.1 Belgium Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.3.10 Portugal
4.3.10.1 Portugal Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4 Asia Pacific
4.4.1 Australia
4.4.1.1 Australia Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4.2 New Zealand
4.4.2.1 New Zealand Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4.3 Japan
4.4.3.1 Japan Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4.4 India
4.4.4.1 India Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.4.5 China
4.4.5.1 China Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.5 Latin America
4.5.1 Brazil
4.5.1.1 Brazil Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.5.2 Mexico
4.5.2.1 Mexico Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.5.3 Argentina
4.5.3.1 Argentina Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
4.5.4 Chile
4.5.4.1 Chile Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)

Chapter 5 Global Deep Brain Stimulation Devices Market Share Analysis
5.1 Market Share Analysis by Key Players of Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
5.1.1 Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Share Analysis, by Key Players, 2012 (%)

Chapter 6 Recommendations
6.1 Success strategies
6.1.1 Rigorous research and development (R&D) activities
6.1.2 Medical device manufacture outsourcing
6.1.3 Increase public and professional awareness
6.1.4 Investing in emerging economies

Chapter 7 Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Profile
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.4.1 Expansion of geographical footprint
7.1.4.2 Acquisitions
7.1.4.3 Recent Developments
7.2 MEDTRONIC, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.4.1 Research and Development investments
7.2.4.2 Patent filling
7.2.4.3 Recent Developments
7.3 St Jude Medical, Inc.
7.3.1 Company Profile
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.4.1 Global expansion with technology advancement
7.3.4.2 Recent Developments
7.4 Sapiens Neuro
7.4.1 Company Overview
7.4.2 Product Portfolio
7.4.3 Business Strategy
7.4.3.1 Business through innovation and excellence
7.4.4 Recent Developments
7.5 Aleva Neurotherapeutics SA
7.5.1 Company Overview
7.5.2 Product Portfolio
7.5.3 Business Strategy
7.5.3.1 Patent filling

List of Figures

FIG. 1 Global : Market Segmentation
FIG. 2 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, Drivers and Restraints
FIG. 3 Porter’s Five Force Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
FIG. 4 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography
FIG. 5 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, by Geography, 2012 & 2019 (Value %)
FIG. 6 U.S. Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 7 Canada Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 8 Germany Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 9 U.K. Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 10 France Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 11 Italy Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 12 Spain Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 13 Poland Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 14 Netherlands Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 15 Greece Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 16 Belgium Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 17 Portugal Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 18 Australia Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 19 New Zealand Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 20 Japan Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 21 India Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 22 China Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 23 Brazil Population Distribution, by Age Groups (1950 – 2050)
FIG. 24 Brazil Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 25 Mexico Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 26 Argentina Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 27 Chile Deep Brain Stimulation Devices Market Revenue for Parkinson’s Disease, 2011 – 2019 (USD Million)
FIG. 28 Global Deep Brain Stimulation Devices for Parkinson’s disease: Market Share, by Key Players, 2012 (%)
FIG. 29 Boston Scientific Corporation: annual sales revenue, USD million, 2010 – 2012
FIG. 30 Medtronic, Inc.: annual sales revenue, USD million, 2010 – 2012
FIG. 31 St Jude Medical: annual sales revenue, USD million, 2010 – 2012

List of Tables

TABLE 1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease
TABLE 2 Relationship Between Age and the Occurrence of Parkinson’s Disease
TABLE 3 Deep Brain Stimulation Device’s U.S. FDA approval for Various Neurological Disorders
TABLE 4 Global Prevalence of Parkinson’s disease, By Geography, 2011 – 2019,
TABLE 5 Number of Parkinson’s Patients Treated with DBS Devices, By Geography, 2011 – 2019
TABLE 6 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, By Geography, 2011 – 2019 (USD Million)
TABLE 7 North America Prevalence of Parkinson’s disease, By Country, 2011 – 2019
TABLE 8 Number of Parkinson’s Patients treated with DBS Devices in North America, By Country, 2011 – 2019
TABLE 9 Average Price of Deep Brain Stimulation Devices in North America, By Country
TABLE 10 Europe Prevalence of Parkinson’s Disease, By Country, 2011 – 2019
TABLE 11 Number of Parkinson’s Patients treated with DBS Devices in Europe, By Country, 2011 – 2019
TABLE 12 Average Price of Deep Brain Stimulation Devices in Europe, By Country
TABLE 13 Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC)
TABLE 14 Asia-Pacific Prevalence of Parkinson’s Disease, By Country, 2011 - 2019
TABLE 15 Number of Parkinson’s Patients treated with DBS Devices in Asia-Pacific, By Country, 2011 – 2019
TABLE 16 Average Price of Deep Brain Stimulation Devices in Asia-Pacific, By Country
TABLE 17 Latin America Prevalence of Parkinson’s Disease, By Country, 2011 - 2019
TABLE 18 Number of Parkinson’s Patients treated with DBS Devices in Latin America, By Country, 2011 – 2019
TABLE 19 Average Price of Deep Brain Stimulation Devices in Latin America, By Country
TABLE 20 Number Parkinson’s Patients Treated with DBS, By Country (2012 & 2013)

A rise in ageing population has been found to be the major causative factor for development of Parkinson’s disease. Parkinson’s disease is the second-most common chronic and progressive neurodegenerative disorder featuring the cardinal symptoms of postural instability, bradykinesia, akinesia and tremors due to loss of dopamine producing neurons in substantia nigra of the mid-brain. The mean age of onset of Parkinson’s disease is 55 to 60 years. According to the Parkinson’s Disease Foundation (PDF), approximately 10 million people are estimated to currently live with Parkinson’s disease globally.

There are multiple treatment options available in the market to treat patients living with Parkinson’s disease. These include chemotherapy, stem cell therapy, physical therapy and surgical treatment. Among drug therapies, the most potent medication is levodopa/Carbidopa therapy. Other drugs used to treat PD are dopamine agonists, anti-cholinergic, MAO-B inhibitors and Catechol-O-Methyltransferase (COMT) inhibitors. However, after long term chemotherapy treatment, the drugs used lose their effectiveness. In the advance stages of Parkinson’s disease surgical intervention becomes imperative. DBS as a surgical intervention is considered to be highly effective and safe as compared to open surgeries such as thalamotomy, pallidotomy and subthalamotomy.

Technological advances have aided the growth of this market. Recently, a research team from the Tel Aviv University has been working on an advanced biometric computer chip implant known as Rehabilitation Nano Chip (ReNaChip) that would support healthcare professionals and neurosurgeons in restoring normal brain functions. The innovative ReNaChip would significantly enhance the existing technology known as DBS by delivering electrical stimulation to the appropriate brain area. In addition, companies such as Boston Scientific has recently introduced its flagship product named “Vercise DBS”. This product is expected to enhance the battery life of the device by 25 years thus competing on pricing with replaceable battery providers for DBS that lasts just for 5 years. Furthermore, an independent unique MICC technology (Multiple Independent Current Control) has been incorporated in Vercise DBS system to control the side-effects of stimulation by controlling the current level at each individual contact on the lead.

Leading players such as Medtronic and St. Jude Medical are continuously investing in research and development to increase the applicability of DBS devices in treating various movement disorders. Currently, the DBS procedure entails implantation of two leads for bilateral stimulation; however, research is currently being carried out to implant multiple lead array systems to stimulate various sites in brain. Thus, the three major players of this market i.e. Medtronic, Boston Scientific and St. Jude have created a strong entry barrier for new entrants and dominate the market. However, few new entrants such as Sapiens Neuro and Aleva Neurotherapeutics SA are expected to launch their new products in next few years, which are currently under clinical trials for treatment of Parkinson’s.

- Aleva Neurotherapeutics SA
- Boston Scientific Corporation
- MEDTRONIC, Inc.
- Sapiens Neuro
- St Jude Medical, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos